Skip to Content

What chemical is released during depression?

Depression is a complex mental health disorder that affects millions of people worldwide. There are many factors that contribute to depression, including genetics, traumatic experiences, medications, and brain chemistry. When it comes to brain chemistry, there are certain chemicals that play a key role in depression.

The Role of Neurotransmitters

Neurotransmitters are chemical messengers in the brain that regulate many aspects of mood and behavior. There are several neurotransmitters implicated in depression:

  • Serotonin – Often called the “happiness” chemical, low levels are linked to depression.
  • Norepinephrine – Important for focus and concentration, low levels associated with low energy.
  • Dopamine – Crucial for feelings of pleasure and reward, low levels cause lack of motivation.

When the delicate balance of these neurotransmitters is disrupted, it can lead to the symptoms of depression. Understanding the specific neurotransmitters involved in depression has enabled the development of antidepressant medications that target these chemical messengers.

The Role of Serotonin

Of the neurotransmitters, the one most directly linked to depression is serotonin. Serotonin is a chemical messenger that regulates mood, social behavior, appetite, digestion, sleep, memory and sexual desire. It’s one of the key chemicals involved in promoting feelings of well-being and happiness.

Research shows that people with depression often have lower levels of serotonin activity in the brain. Many antidepressant medications used to treat depression work by increasing serotonin levels. These include:

  • Selective serotonin reuptake inhibitors (SSRIs)
  • Serotonin and norepinephrine reuptake inhibitors (SNRIs)
  • Monoamine oxidase inhibitors (MAOIs)
  • Tricyclic antidepressants (TCAs)

The most commonly prescribed antidepressants are SSRIs such as Prozac, Zoloft and Lexapro. By preventing the reabsorption (reuptake) of serotonin, these drugs allow more serotonin to remain available in the brain. Increased serotonin enhances mood and emotions.

Low Serotonin Levels

Research has found that people with depression often have lower levels of serotonin activity in the brain. This can occur for several reasons:

  • Low serotonin production – The body produces less serotonin.
  • Lack of receptor sites – Not enough receptor sites for serotonin to bind to.
  • Increased serotonin breakdown – More rapid breakdown and removal of serotonin.

Genetics play a role in serotonin regulation and production. People with a family history of depression may be prone to low serotonin activity. Traumatic early life events and major stress can also affect serotonin levels later in life.

Testing Serotonin Levels

While research shows a link between low serotonin and depression, there currently isn’t a clinical test available to directly measure serotonin levels in the living human brain. Scientists have developed some new positron emission tomography (PET) scanning techniques to view serotonin receptors and transporters which indirectly reflect serotonin levels. However, PET scanning is still primarily a research tool, not used routinely in clinical practice.

There are some preliminary blood and urine tests being researched to detect levels of serotonin metabolites as an indicator of serotonin activity, but more validation is needed before they are used clinically.

Other Neurochemicals Involved

In addition to serotonin, other neurotransmitters play a role in depression:

Norepinephrine

Norepinephrine is important for focus, concentration, motivation and drive. Low norepinephrine activity is linked to low energy, lack of motivation, fatigue and difficulty concentrating in depression.

Dopamine

Dopamine is crucial for experiencing pleasure, reward-motivated behavior, and feelings of accomplishment. Low dopamine is associated with loss of interest in pleasurable activities, decreased motivation and lack of enjoyment.

BDNF

Brain-derived neurotrophic factor (BDNF) is a protein that stimulates growth of neurons. Low levels of BDNF are implicated in decreased brain plasticity and neurogenesis, which may play a role in depression.

GABA

Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that regulates nervous system activity. Low GABA can lead to anxiety, restlessness and rumination associated with depression.

The Stress Hormone Connection

In addition to neurotransmitters, researchers have identified links between depression and key hormones, particularly cortisol. Cortisol is a hormone released by the adrenal glands in response to stress.

While normal levels of cortisol help manage stress, chronic stress and elevated cortisol levels have been strongly correlated with clinical depression:

  • Chronic stress leads to overactivation of the hypothalamic-pituitary-adrenal (HPA) axis, which regulates cortisol.
  • Excessive cortisol release negatively impacts mood, energy, immune function and serotonin activity.
  • Depressed patients frequently have elevated cortisol levels, disrupted circadian rhythms and impaired cortisol negative feedback loops.

Normalizing cortisol levels through stress reduction, lifestyle changes, therapy and medications can improve depressive symptoms. There is even some research indicating antidepressants may work in part by regulating cortisol levels.

Inflammatory Factors

Systemic inflammation in the body may also be implicated in some cases of depression:

  • Inflammation markers like C-reactive protein (CRP) and pro-inflammatory cytokines are often elevated in those with depression.
  • Chronic inflammation may promote decreased serotonin and other neurochemical abnormalities.
  • Anti-inflammatory agents and lifestyle changes may improve depressive symptoms and support mental health.

The Gut-Brain Connection

An emerging area of research explores the gut-brain axis in depression. There appears to be complex interplay between the gut microbiome and brain function through pathways like the vagus nerve, immune system signaling, tryptophan levels, and production of neuroactive compounds like serotonin by gut bacteria.

  • Dysbiosis and leaky gut syndrome are associated with increased depression risk.
  • Probiotics and prebiotics may have potential to improve mood by impacting gut microbiota.
  • Dietary components like fiber, polyphenols and omega-3s may provide mental health benefits by optimizing the gut environment.

Oxidative Stress and Mitochondrial Dysfunction

Ongoing research is examining the role of oxidative stress and mitochondrial dysfunction in depression:

  • Oxidative damage to neurons may contribute to decreased brain plasticity.
  • Impaired energy metabolism in brain cells could negatively impact neurotransmitter production.
  • Antioxidants like vitamin C, vitamin E and glutathione may have applications in supporting mental health.

Neuroendocrine Disruption

Hormonal influences like hypothyroidism, premenstrual dysphoric disorder, perimenopause and postpartum depression highlight the sensitivity of mental health to neuroendocrine fluctuations:

  • Imbalances in thyroid hormones, estrogen and progesterone can precipitate or exacerbate underlying mood disorders.
  • Carefully managing endocrine status through lifestyle, supplements and medications can often improve depressive symptoms.

Genetic Factors

Research demonstrates genetics play a substantial role in depression susceptibility:

  • Having a first-degree relative with depression increases risk.
  • Certain genetic variants affect serotonin signaling, HPA axis function, inflammation, BDNF and more.
  • Gene-environment interactions determine how genetic vulnerabilities are expressed after stress exposure.

Neuroanatomical Differences

Brain imaging techniques reveal visible brain changes in people with depression:

  • Reduced hippocampal and prefrontal cortex volumes from neurotoxicity and loss of neuroplasticity.
  • Hyperactivity in the amygdala related to heightened fear, anxiety and emotional processing.
  • Decreased activity in reward circuits involving the basal ganglia and nucleus accumbens.

These structural and functional brain changes shed light on the complex neurobiology underlying depression.

Conclusion

In summary, depression is associated with dysregulation of multiple neurotransmitters, hormones, inflammatory signals and other pathways in the brain and body. While serotonin is the chemical most directly linked to depressive symptoms, current research emphasizes the interconnected nature of the body’s systems in mental health. An integrative treatment approach targeting inflammation, HPA axis function, gut health, stress management and nutrition alongside conventional therapy provides the optimal strategy for balancing the biochemistry of depression.